| P2093 | author name string | Layne Dylla | |
| | Paul Jedlicka | |
| P2860 | cites work | Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 |
| | Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia | Q24633394 |
| | Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters | Q24645192 |
| | Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas | Q24652219 |
| | miR-19 is a key oncogenic component of mir-17-92 | Q24652326 |
| | miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. | Q24653347 |
| | EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma | Q27851507 |
| | c-Myc-regulated microRNAs modulate E2F1 expression | Q27861046 |
| | MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E | Q28117082 |
| | The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia | Q28269786 |
| | E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer | Q28271985 |
| | mir-17-92, a cluster of miRNAs in the midst of the cancer network | Q28275929 |
| | Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92 | Q28294917 |
| | The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors | Q28295428 |
| | Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling | Q28297583 |
| | The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities | Q28297958 |
| | Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia | Q28306681 |
| | Regulation of mRNA translation and stability by microRNAs | Q29547304 |
| | MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells | Q29616080 |
| | Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. | Q31157886 |
| | Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology Group | Q33559559 |
| | Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group | Q33813608 |
| | Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling. | Q33877588 |
| | Overexpression of microRNAs from the miR-17-92 paralog clusters in AIDS-related non-Hodgkin's lymphomas | Q33940931 |
| | Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo. | Q33986152 |
| | Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development | Q33997274 |
| | miR-15a/16-1 influences BCL2 expression in keratocystic odontogenic tumors. | Q54305835 |
| | Ewing's sarcoma origin: from duel to duality | Q84386241 |
| | R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis | Q34055933 |
| | Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation | Q34109986 |
| | MicroRNA sponges: progress and possibilities | Q34139023 |
| | Targeted Therapy of Ewing's Sarcoma | Q34262377 |
| | Biology of EWS/ETS fusions in Ewing's family tumors | Q34405501 |
| | Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group | Q34694293 |
| | The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim | Q34979616 |
| | Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. | Q35606800 |
| | Mouse miRNA-709 directly regulates miRNA-15a/16-1 biogenesis at the posttranscriptional level in the nucleus: evidence for a microRNA hierarchy system | Q35796875 |
| | Discovering the first microRNA-targeted drug | Q36353486 |
| | Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family | Q36405766 |
| | Recent advances in the molecular pathogenesis of Ewing's sarcoma | Q36562720 |
| | Locked nucleic acid holds promise in the treatment of cancer | Q37160953 |
| | Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future | Q37182432 |
| | Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. | Q37272418 |
| | Gene expression profile of ewing sarcoma cell lines differing in their EWS-FLI1 fusion type. | Q38320073 |
| | MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor | Q38321646 |
| | A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs | Q38334606 |
| | Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma | Q38338166 |
| | miR-106a–mediated Malignant Transformation of Cells Induced by Anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide | Q38340387 |
| | A TARBP2-dependent miRNA expression profile underlies cancer stem cell properties and provides candidate therapeutic reagents in Ewing sarcoma | Q39331421 |
| | WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells | Q39340936 |
| | Vector-based miR-15a/16-1 plasmid inhibits colon cancer growth in vivo | Q39350883 |
| | Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells | Q39371337 |
| | miR-106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS. | Q39376733 |
| | Nucleolin protein interacts with microprocessor complex to affect biogenesis of microRNAs 15a and 16. | Q39448784 |
| | miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy | Q39465507 |
| | EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model | Q40142173 |
| | The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms. | Q45927530 |
| | Efficient in vivo microRNA targeting of liver metastasis | Q46584676 |
| | Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation | Q47302451 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e63032 | |
| P577 | publication date | 2013-04-26 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma | |
| P478 | volume | 8 | |